Zhong H - Search Results

1

Exploring Cr and molten salt interfacial interactions for molten salt applications.

Liu X, Liu Y, Gibson LD, Ge M, Olds D, Leshchev D, Bai J, Plonka AM, Halstenberg P, Zhong H, Ghose S, Lin CH, Zheng X, Xiao X, Lee WK, Dai S, Samolyuk GD, Bryantsev VS, Frenkel AI, Chen-Wiegart YK. Liu X, et al. Among authors: zhong h. Phys Chem Chem Phys. 2024 Jun 3. doi: 10.1039/d4cp01122h. Online ahead of print. Phys Chem Chem Phys. 2024. PMID: 38829308

2

Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis.

Cheng Q, Sun J, Zhong H, Wang Z, Liu C, Zhou S, Deng J. Cheng Q, et al. Among authors: zhong h. Front Pharmacol. 2024 May 17;15:1393333. doi: 10.3389/fphar.2024.1393333. eCollection 2024. Front Pharmacol. 2024. PMID: 38828451 Free PMC article.

3

Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial.

Wang F, Shen L, Guo W, Liu T, Li J, Qin S, Bai Y, Chen Z, Wang J, Pan Y, Shu Y, Zhao F, Cheng Y, Ye F, Gu K, Zhang T, Pan H, Zhong H, Zhou F, Qin Y, Yang L, Mao W, Li Q, Dai W, Li W, Wang S, Tang Y, Ma D, Yin X, Deng Y, Yuan Y, Li M, Hu W, Chen D, Li G, Liu Q, Tan P, Fan S, Shi M, Su W, Xu RH. Wang F, et al. Among authors: zhong h. Nat Med. 2024 Jun 1. doi: 10.1038/s41591-024-02989-6. Online ahead of print. Nat Med. 2024. PMID: 38824242

4

Co-prescription of naloxone in patients prescribed opioids after hospital stays in the USA.

Illescas A, Liu J, Zhong H, Reisinger L, Cozowicz C, Poeran J, Memtsoudis SG. Illescas A, et al. Among authors: zhong h. Br J Anaesth. 2024 May 30:S0007-0912(24)00278-2. doi: 10.1016/j.bja.2024.04.054. Online ahead of print. Br J Anaesth. 2024. PMID: 38821750 No abstract available.

5

Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance.

Mao JX, Li JJ, Lu XY, Zhong HX, Zhao YY, Zhu LY, Fu H, Ding GS, Teng F, Chen M, Guo WY. Mao JX, et al. Among authors: zhong hx. Int Immunopharmacol. 2024 May 30;136:112340. doi: 10.1016/j.intimp.2024.112340. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38820962

6

Nutritional Management of Lung Cancer Patients Undergoing Chemotherapy: A Qualitative Exploration of Patients' and Healthcare Professionals' Perspectives.

Rong H, Li F, Liu C, Zhou L, Zhong H, Li L, Xiao T, Xiao R, Chen X. Rong H, et al. Among authors: zhong h. Semin Oncol Nurs. 2024 May 29:151657. doi: 10.1016/j.soncn.2024.151657. Online ahead of print. Semin Oncol Nurs. 2024. PMID: 38816314

7

Intestinal CXCR6⁺ ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression.

Liang Z, Tang Z, Zhu C, Li F, Chen S, Han X, Zheng R, Hu X, Lin R, Pei Q, Yin C, Wang J, Tang C, Cao N, Zhao J, Wang R, Li X, Luo N, Wen Q, Yu J, Li J, Xia X, Zheng X, Wang X, Huang N, Zhong Z, Mo C, Chen P, Wang Y, Fan J, Guo Y, Zhong H, Liu J, Peng Z, Mao H, Shi GP, Bonventre JV, Chen W, Zhou Y. Liang Z, et al. Among authors: zhong h. Immunity. 2024 May 21:S1074-7613(24)00255-3. doi: 10.1016/j.immuni.2024.05.004. Online ahead of print. Immunity. 2024. PMID: 38815582

8

Efficacy and safety of targeted therapy plus immunotherapy combined with hepatic artery infusion chemotherapy (FOLFOX) for unresectable hepatocarcinoma.

Lin ZP, Hu XL, Chen D, Huang DB, Zou XG, Zhong H, Xu SX, Chen Y, Li XQ, Zhang J. Lin ZP, et al. Among authors: zhong h. World J Gastroenterol. 2024 May 7;30(17):2321-2331. doi: 10.3748/wjg.v30.i17.2321. World J Gastroenterol. 2024. PMID: 38813052 Free PMC article.

9

Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.

Shi ZY, Fang Y, Xu PP, Yi HM, Li JF, Dong Y, Zhu Y, Liu MK, Fu D, Wang S, Shi Q, Shen R, Zhong HJ, Wang CF, Cheng S, Wang L, Liu F, Zhao WL. Shi ZY, et al. Among authors: zhong hj. Clin Transl Med. 2024 Jun;14(6):e1691. doi: 10.1002/ctm2.1691. Clin Transl Med. 2024. PMID: 38812093 Free PMC article. No abstract available.

10

Spatial analysis of digital economy and its driving factors: A case study of the Yangtze River Delta City Cluster in China.

Zhong H, Wang B, Zhang S. Zhong H, et al. PLoS One. 2024 May 29;19(5):e0300443. doi: 10.1371/journal.pone.0300443. eCollection 2024. PLoS One. 2024. PMID: 38809893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,420 results

Search Page